254 related articles for article (PubMed ID: 38023127)
1. Carbohydrate antigen 125 in congestive heart failure: ready for clinical application?
Feng R; Zhang Z; Fan Q
Front Oncol; 2023; 13():1161723. PubMed ID: 38023127
[TBL] [Abstract][Full Text] [Related]
2. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
Núñez J; de la Espriella R; Miñana G; Santas E; Llácer P; Núñez E; Palau P; Bodí V; Chorro FJ; Sanchis J; Lupón J; Bayés-Genís A
Eur J Heart Fail; 2021 Sep; 23(9):1445-1457. PubMed ID: 34241936
[TBL] [Abstract][Full Text] [Related]
3. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
4. CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.
Núñez-Marín G; de la Espriella R; Santas E; Lorenzo M; Miñana G; Núñez E; Bodí V; González M; Górriz JL; Bonanad C; Sanchis J; Bayés-Genís A; Núñez J
Eur Heart J Acute Cardiovasc Care; 2021 Jun; 10(5):475-483. PubMed ID: 33829233
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.
Miñana G; de la Espriella R; Mollar A; Santas E; Núñez E; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; Martí-Cervera J; Sanchis J; Bayés-Genís A; Núñez J
Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):437-447. PubMed ID: 32129669
[TBL] [Abstract][Full Text] [Related]
6. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure.
Llàcer P; Gallardo MÁ; Palau P; Moreno MC; Castillo C; Fernández C; de la Espriella R; Mollar A; Santas E; Miñana G; Manzano L; Bayés-Genís A; Núñez J
Med Clin (Barc); 2021 Jun; 156(12):589-594. PubMed ID: 32951882
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate Antigen 125: A Biomarker at the Crossroads of Congestion and Inflammation in Heart Failure.
Kumric M; Kurir TT; Bozic J; Glavas D; Saric T; Marcelius B; D'Amario D; Borovac JA
Card Fail Rev; 2021 Mar; 7():e19. PubMed ID: 34950509
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate antigen 125 predicts pulmonary congestion in patients with ST-segment elevation myocardial infarction.
Falcão FJA; Oliveira FRA; Cantarelli F; Cantarelli R; Brito-Júnior P; Lemos H; Silva P; Camboim I; Freire MC; Carvalho O; Sobral-Filho DC
Braz J Med Biol Res; 2019; 52(12):e9124. PubMed ID: 31826182
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure.
Marinescu MC; Oprea VD; Munteanu SN; Nechita A; Tutunaru D; Nechita LC; Romila A
Diagnostics (Basel); 2024 Apr; 14(8):. PubMed ID: 38667440
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate antigen 125 combined with N-terminal pro-B-type natriuretic peptide in the prediction of acute heart failure following ST-elevation myocardial infarction.
Xu K; Wu M; Huang M; Zhuo X; Weng Y; Chen X
Medicine (Baltimore); 2022 Dec; 101(48):e32129. PubMed ID: 36482545
[TBL] [Abstract][Full Text] [Related]
13. Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
Núñez J; de la Espriella R; Rossignol P; Voors AA; Mullens W; Metra M; Chioncel O; Januzzi JL; Mueller C; Richards AM; de Boer RA; Thum T; Arfsten H; González A; Abdelhamid M; Adamopoulos S; Anker SD; Gal TB; Biegus J; Cohen-Solal A; Böhm M; Emdin M; Jankowska EA; Gustafsson F; Hill L; Jaarsma T; Jhund PS; Lopatin Y; Lund LH; Milicic D; Moura B; Piepoli MF; Ponikowski P; Rakisheva A; Ristic A; Savarese G; Tocchetti CG; Van Linthout S; Volterrani M; Seferovic P; Rosano G; Coats AJS; Bayes-Genis A
Eur J Heart Fail; 2022 Oct; 24(10):1751-1766. PubMed ID: 36039656
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of antigen carbohydrate 125 for planning the optimal length of stay in acute heart failure.
Lorenzo M; Palau P; Llàcer P; Domínguez E; Ventura B; Núñez G; Miñana G; Solsona J; Santas E; De La Espriella R; Bodí V; Núñez E; Sanchis J; Bayés-Genís A; Núñez J
Eur J Intern Med; 2021 Oct; 92():94-99. PubMed ID: 34130879
[TBL] [Abstract][Full Text] [Related]
15. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
16. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
[TBL] [Abstract][Full Text] [Related]
17. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
Núñez J; Bayés-Genís A; Revuelta-López E; Miñana G; Santas E; Ter Maaten JM; de la Espriella R; Carratalá A; Lorenzo M; Palau P; Llàcer P; Valle A; Bodi V; Núñez E; Lupón J; Lang C; Ng LL; Metra M; Sanchis J; Voors AA
Rev Esp Cardiol (Engl Ed); 2022 Apr; 75(4):316-324. PubMed ID: 33745912
[TBL] [Abstract][Full Text] [Related]
18. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
19. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
20. Value of BNP and tumour marker CA125 in patients with heart failure.
Chen YX; Wang XQ; Fang CF; Wang JF; Tang LJ
Acta Cardiol; 2008 Aug; 63(4):501-6. PubMed ID: 18795589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
